JSM2024
Back to the program
Contributed Papers

Dose Finding in Oncology Clinical Trials

Mon, Aug 5, 10:30 AM - 12:20 PM
Hongwei WangChair
Biopharmaceutical Section

6 Presentations

Application of i3+3 design in phase I dose-finding clinical trials
10:35 AM - 10:50 AM
Jing Zhang
Co-authors: Karen Messer (UCSD Division of Biostatistics and Bioiformatics)
Design Integrating Dose Optimization and Component Contribution Assessment for Combination Therapy
10:50 AM - 11:05 AM
Xiaohan Chi
Co-authors: Ruitao Lin (University of Texas, MD Anderson Cancer Center), Ying Yuan (University of Texas, MD Anderson Cancer Center)
How Much is Too Much – Dose Intensity for Oncological Clinical Trials
11:05 AM - 11:20 AM
Yaling Teng (AbbVie)
Improved Approaches to Intra-patient Dose Escalation in Phase I Oncology Trials
11:20 AM - 11:35 AM
Chloe Falke (University of Minnesota)
Co-authors: Joseph Koopmeiners (University of Minnesota)
Integration of Dose Optimization into a 2-in-1 Adaptive Design for Oncology Drug
11:35 AM - 11:50 AM
Yayan Zhang (Eikon Therapeutics, Inc.)
Co-authors: Meihua Wang
Seamless Phase 2/3 Oncology Confirmatory Trials with Dose Optimization and Sample Size Re-estimation
11:50 AM - 12:05 PM
Haiming Zhou (Daiichi Sankyo, Inc.)
Co-authors: Philip He (Daiichi Sankyo Inc.)
↑